Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.28 SEK | -2.32% | +17.47% | +11.14% |
04-25 | Polygiene Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-15 | Polygiene Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 128M 11.68M 936M | Sales 2025 * | 144M 13.08M 1.05B | Capitalization | 339M 30.85M 2.47B |
---|---|---|---|---|---|
Net income 2024 * | -4M -364K -29.17M | Net income 2025 * | 6M 546K 43.76M | EV / Sales 2024 * | 2.38 x |
Net cash position 2024 * | 34M 3.09M 248M | Net cash position 2025 * | 38M 3.46M 277M | EV / Sales 2025 * | 2.09 x |
P/E ratio 2024 * |
-84.4
x | P/E ratio 2025 * |
51.6
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.11% |
1 day | -2.32% | ||
1 week | +17.47% | ||
Current month | +20.99% | ||
1 month | +20.99% | ||
3 months | +28.18% | ||
6 months | +109.01% | ||
Current year | +11.14% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 09/05/17 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 14/09/22 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 31/12/18 | |
Director/Board Member | 71 | 10/05/23 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 31/12/17 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 9.28 | -2.32% | 1,031 |
29/04/24 | 9.5 | -0.84% | 43,605 |
26/04/24 | 9.58 | +5.04% | 19,063 |
25/04/24 | 9.12 | +14.00% | 113,795 |
24/04/24 | 8 | +1.27% | 8,047 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 10:45 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.14% | 30.86M | |
+13.36% | 64.66B | |
-3.80% | 46.08B | |
+13.26% | 39.72B | |
+19.28% | 25.82B | |
+8.22% | 18.8B | |
-0.89% | 17.14B | |
-21.03% | 15.86B | |
+1.06% | 15.05B | |
-18.04% | 14.14B |
- Stock Market
- Equities
- POLYG Stock